These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19825807)

  • 1. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.
    To KK; Robey RW; Knutsen T; Zhan Z; Ried T; Bates SE
    Mol Cancer Ther; 2009 Oct; 8(10):2959-68. PubMed ID: 19825807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells.
    Li X; Pan YZ; Seigel GM; Hu ZH; Huang M; Yu AM
    Biochem Pharmacol; 2011 Mar; 81(6):783-92. PubMed ID: 21219875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.
    To KK; Zhan Z; Litman T; Bates SE
    Mol Cell Biol; 2008 Sep; 28(17):5147-61. PubMed ID: 18573883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
    Ripperger A; Benndorf RA
    Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells.
    Padmanabhan R; Chen KG; Gillet JP; Handley M; Mallon BS; Hamilton RS; Park K; Varma S; Mehaffey MG; Robey PG; McKay RD; Gottesman MM
    Stem Cells; 2012 Oct; 30(10):2175-87. PubMed ID: 22887864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations.
    Wang F; Xue X; Wei J; An Y; Yao J; Cai H; Wu J; Dai C; Qian Z; Xu Z; Miao Y
    Br J Cancer; 2010 Aug; 103(4):567-74. PubMed ID: 20628378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
    Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ
    Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
    Pan YZ; Morris ME; Yu AM
    Mol Pharmacol; 2009 Jun; 75(6):1374-9. PubMed ID: 19270061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression.
    Turrini E; Haenisch S; Laechelt S; Diewock T; Bruhn O; Cascorbi I
    Pharmacogenet Genomics; 2012 Mar; 22(3):198-205. PubMed ID: 22241070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.
    Bram EE; Ifergan I; Grimberg M; Lemke K; Skladanowski A; Assaraf YG
    Biochem Pharmacol; 2007 Jun; 74(1):41-53. PubMed ID: 17481587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
    Guo J; Jin D; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Miao S; Xi S
    EBioMedicine; 2018 Sep; 35():204-221. PubMed ID: 30146342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
    Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
    Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1.
    Pan YZ; Zhou A; Hu Z; Yu AM
    Drug Metab Dispos; 2013 Oct; 41(10):1744-51. PubMed ID: 23686318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
    Reustle A; Fisel P; Renner O; B├╝ttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
    Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells.
    To KK; Ren SX; Wong CC; Cho CH
    Peptides; 2013 Feb; 40():13-21. PubMed ID: 23274176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
    Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
    J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.